Jan Kisielow

Jan Kisielow

Auto-generated profile, based on publicly available information

Jan Kisielow

Repertoire Immune Medicines, Schlieren, Switzerland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2009 in Science
Verified
Journal Article
Closed access
PDF file
AFAnja Fröhlich
Anja Fröhlich
JKJan Kisielow
Jan Kisielow
ISIwana Schmitz
Iwana Schmitz
SFStefan Freigang
Stefan Freigang
ASAbdijapar T. Shamshiev
Abdijapar T. Shamshiev
MKManfred Kopf
Manfred Kopf
Controlling Chronic Viral Infections: Chronic viral infections such as HIV and hepatitis B and C viruses are major public health concerns. T cell—mediated immune responses are critical for controlling viral infections. In contrast to acute infections, chronic viral infections are characterized by “exhausted” cytotoxic CD8 + T cells, cells which exhibit reduced proliferative capacity, cytokine secretion, and cytotoxicity. Treatments that reverse exhaustion result in increased viral control. Despite their exhaustion, these CD8 + T cells eventually help to control chronic infections by killing virally infected cells, and require CD4 + T cell help to do so. How do CD4 + T cells provide help to CD8 + T cells during chronic infection (see the Perspective by Johnson and Jameson )? Elsaesser et al. (p. 1569 , published online 7 May), Yi et al. (p. 1572 , published online 14 May), and Fröhlich et al. (p. 1576 , published online 28 May) now show that the cytokine, interleukin-21 (IL-21), known to be critical for the differentiation of certain CD4 + T cell effector subsets, is an essential factor produced by CD4 + T cells that helps CD8 + T cells to control chronic lymphocytic choriomeningitis virus infection in mice. Acute and chronic infections resulted in differing amounts of IL-21 production by virus-specific CD4 + T cells. CD8 + T cells required IL-21 directly, and when CD8 + T cells were unable to signal through IL-21 or IL-21 was not available, they were reduced in number, exhibited a more exhausted phenotype, and were not able to control the virus. In contrast, the absence of IL-21–dependent signaling did not affect primary CD8 + T cell responses to acute infection or responses to a viral rechallenge, suggesting that differentiation of memory CD8 + T cells is independent of IL-21.

15 October 2012 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
LTLuigi Tortola
Luigi Tortola
EREsther Rosenwald
Esther Rosenwald
BABrian Abel
Brian Abel
HBHal Blumberg
Hal Blumberg
MSMatthias Schäfer
Matthias Schäfer
MKManfred Kopf
Manfred Kopf
Psoriasis is a chronic inflammatory disorder of the skin affecting approximately 2% of the world’s population. Accumulating evidence has revealed that the IL-23/IL-17/IL-22 pathway is key for development of skin immunopathology. However, the role of keratinocytes and their crosstalk with immune cells at the onset of disease remains poorly understood. Here, we show that IL-36R–deficient (Il36r–/–) mice were protected from imiquimod-induced expansion of dermal IL-17–producing γδ T cells and psoriasiform dermatitis. Furthermore, IL-36R antagonist-deficient (Il36rn–/–) mice showed exacerbated pathology. TLR7 ligation on DCs induced IL-36–mediated crosstalk with keratinocytes and dermal mesenchymal cells that was crucial for control of the pathological IL-23/IL-17/IL-22 axis and disease development. Notably, mice lacking IL-23, IL-17, or IL-22 were less well protected from disease compared with Il36r–/– mice, indicating an additional distinct activity of IL-36 beyond induction of the pathological IL-23 axis. Moreover, while the absence of IL-1R1 prevented neutrophil infiltration, it did not protect from acanthosis and hyperkeratosis, demonstrating that neutrophils are dispensable for disease manifestation. These results highlight a central and unique IL-1–independent role for IL-36 in control of the IL-23/IL-17/IL-22 pathway and development of psoriasiform dermatitis.

12 April 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SFStefan Freigang
Stefan Freigang
FAFranziska Ampenberger
Franziska Ampenberger
GSGunther Spohn
Gunther Spohn
SHSebastian Heer
Sebastian Heer
ASAbdijapar T. Shamshiev
Abdijapar T. Shamshiev
MKManfred Kopf
Manfred Kopf
Oxidative stress and inflammation — two components of the natural host response to injury — constitute important etiologic factors in atherogenesis. The pro‐inflammatory cytokine interleukin (IL)‐1 significantly enhances atherosclerosis, however, the molecular mechanisms of IL‐1 induction within the artery wall remain poorly understood. Here we have identified the oxidative stress‐responsive transcription factor NF‐E2‐related 2 (Nrf2) as an essential positive regulator of inflammasome activation and IL‐1‐mediated vascular inflammation. We show that cholesterol crystals, which accumulate in atherosclerotic plaques, represent an endogenous danger signal that activates Nrf2 and the NLRP3 inflammasome. The resulting vigorous IL‐1 response critically depended on expression of Nrf2, and Nrf2‐deficient apolipoprotein E (Apoe)−/− mice were highly protected against diet‐induced atherogenesis. Importantly, therapeutic neutralization of IL‐1α and IL‐1β reduced atherosclerosis in Nrf2+/−Apoe−/− but not in Nrf2−/−Apoe−/− mice, suggesting that the pro‐atherogenic effect of Nrf2‐signaling was primarily mediated by its permissive role in IL‐1 production. Our studies demonstrate a role for Nrf2 in inflammasome activation, and identify cholesterol crystals as disease‐relevant triggers of the NLRP3 inflammasome and potent pro‐atherogenic cytokine responses. These findings suggest a common pathway through which oxidative stress and metabolic danger signals converge and mutually perpetuate the chronic vascular inflammation that drives atherosclerosis.

30 June 2005 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
MKMalgorzata Kisielow
Malgorzata Kisielow
JKJan Kisielow
Jan Kisielow
GCGiuseppina Capoferri-Sollami
Giuseppina Capoferri-Sollami
KKKlaus Karjalainen
Klaus Karjalainen
Lymphocyte activation gene 3 (LAG-3/CD223) is a CD4 homolog known to be selectively expressed in activated T and NK cells. It is thought to have a negative regulatory function in T cells. With the help of new monoclonal antibodies against mouse LAG-3, we show that LAG-3 surface expression is not limited to activated T and NK cells but is also found on activated B cells. Induction of B cell surface expression is T cell dependent and mediated by a soluble factor. The majority of LAG-3 on B cell surface is endogenously produced, even though soluble LAG-3 is present in the culture supernatants and can be passively absorbed. As B cells express LAG-3 in a T cell dependent manner and not when activated by Toll-like-receptor agonists alone, we propose LAG-3 as a new marker of T cell induced B cell activation.

25 June 2008 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
ISIvo Sonderegger
Ivo Sonderegger
JKJan Kisielow
Jan Kisielow
RMReto Meier
Reto Meier
Cecile KingCecile King
Cecile King
MKManfred Kopf
Manfred Kopf
Th17 cells have been recognized as the central effectors in organ‐related autoimmune diseases. IL‐6 is a key factor that reciprocally regulates Th17 and Foxp3+ Treg differentiation by inhibition of TGF‐β induced Foxp3 and induction of RORγt, a Th17 lineage‐specific transcription factor. Recently IL‐21 has been suggested to induce RORγt and Th17 development in the absence of IL‐6. However, the relevance of IL‐21 for Th17‐dependent inflammatory responses in vivo remains unclear. In this study, we demonstrate that differentiation of IL‐17‐producing CD4 T cells, their recruitment to inflamed organs, and the development of autoimmune disease was not affected in il21R–/– and il21–/– mice in models of myelin oligodendrocyte glycoprotein‐induced autoimmune encephalitis and autoimmune myocarditis. IL‐6 induced Th17 differentiation independent of and much more potently than IL‐21 in vitro. These data suggest that IL‐6 is sufficient to drive Th17 development and associated autoimmunity in vivo in the absence of IL‐21 or IL‐21R.See accompanying Commentary http:dx.doi.org/10.1002/eji.200838529Supporting information for this article is available at http://www.wiley‐vch.de/contents/jc_2040/2008/38511_s.pdf

10 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJonathan Muri
Jonathan Muri
SHSebastian Heer
Sebastian Heer
MMMai Matsushita
Mai Matsushita
LPLea Pohlmeier
Lea Pohlmeier
LTLuigi Tortola
Luigi Tortola
MKManfred Kopf
Manfred Kopf
The thioredoxin-1 (Trx1) system is an important contributor to cellular redox balance and is a sensor of energy and glucose metabolism. Here we show critical c-Myc-dependent activation of the Trx1 system during thymocyte and peripheral T-cell proliferation, but repression during T-cell quiescence. Deletion of thioredoxin reductase-1 (Txnrd1) prevents expansion the CD4−CD8− thymocyte population, whereas Txnrd1 deletion in CD4+CD8+ thymocytes does not affect further maturation and peripheral homeostasis of αβT cells. However, Txnrd1 is critical for expansion of the activated T-cell population during viral and parasite infection. Metabolomics show that TrxR1 is essential for the last step of nucleotide biosynthesis by donating reducing equivalents to ribonucleotide reductase. Impaired availability of 2′-deoxyribonucleotides induces the DNA damage response and cell cycle arrest of Txnrd1-deficient T cells. These results uncover a pivotal function of the Trx1 system in metabolic reprogramming of thymic and peripheral T cells and provide a rationale for targeting Txnrd1 in T-cell leukemia.